Search Results - "Hernando, Raymundo"
-
1
Plasma BDNF levels vary in relation to body weight in females
Published in PloS one (02-07-2012)“…Brain derived neurotrophic factor (BDNF) has been implicated in the pathophysiology of depression as well as neuropsychiatric and neurodegenerative disorders…”
Get full text
Journal Article -
2
Lower CSF Amyloid Beta Peptides and Higher F2-Isoprostanes in Cognitively Intact Elderly Individuals With Major Depressive Disorder
Published in The American journal of psychiatry (01-05-2012)“…Objective:Major depressive disorder is common in the elderly, and symptoms are often not responsive to conventional antidepressant treatment, especially in the…”
Get full text
Journal Article -
3
State-dependent alterations in cerebrospinal fluid Aβ42 levels in cognitively intact elderly with late-life major depression
Published in Neuroreport (28-09-2016)“…Depression has been linked to Alzheimer’s disease as either an increased risk factor for its development or as a prodromal symptom. The neurobiological basis…”
Get full text
Journal Article -
4
Increased Mental Slowing Associated With the APOE ε4 Allele After Trihexyphenidyl Oral Anticholinergic Challenge in Healthy Elderly
Published in The American journal of geriatric psychiatry (2008)“…Objectives The objectives of this study were to examine the relationship between APOE ε4 and subjective effects of trihexyphenidyl on measures reflecting…”
Get full text
Journal Article -
5
The effect of mifepristone (RU 486) on plasma cortisol in Alzheimer's disease
Published in Neurochemical research (01-05-2006)“…The glucocorticoid receptor (GR) antagonist mifepristone (RU-486) has been reported to increase early morning plasma ACTH/cortisol in diverse non-demented…”
Get full text
Journal Article -
6
Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease
Published in Nature communications (17-01-2020)“…In Alzheimer’s diseases (AD), tau pathology is strongly associated with cognitive decline. Preclinical evidence suggests that tau spreads across connected…”
Get full text
Journal Article -
7
Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer’s Pathophysiology
Published in Scientific reports (19-02-2020)“…Causal Structure Discovery (CSD) is the problem of identifying causal relationships from large quantities of data through computational methods. With the…”
Get full text
Journal Article -
8
Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease
Published in Nature communications (04-11-2022)“…For optimal design of anti-amyloid-β (Aβ) and anti-tau clinical trials, we need to better understand the pathophysiological cascade of Aβ- and tau-related…”
Get full text
Journal Article -
9
Type 2 diabetes mellitus, brain atrophy, and cognitive decline
Published in Neurology (19-02-2019)“…OBJECTIVETo study longitudinal relationships between type 2 diabetes mellitus (T2DM), cortical thickness, and cognitive function in older people with normal…”
Get full text
Journal Article -
10
Brain multiplexes reveal morphological connectional biomarkers fingerprinting late brain dementia states
Published in Scientific reports (07-03-2018)“…Accurate diagnosis of mild cognitive impairment (MCI) before conversion to Alzheimer’s disease (AD) is invaluable for patient treatment. Many works showed that…”
Get full text
Journal Article -
11
KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer’s disease
Published in Nature communications (22-06-2021)“…Klotho-VS heterozygosity (KL-VS het ) is associated with reduced risk of Alzheimer’s disease (AD). However, whether KL-VS het is associated with lower levels…”
Get full text
Journal Article -
12
Tau‐Atrophy Variability Reveals Phenotypic Heterogeneity in Alzheimer's Disease
Published in Annals of neurology (01-11-2021)“…Objective Tau neurofibrillary tangles (T) are the primary driver of downstream neurodegeneration (N) and subsequent cognitive impairment in Alzheimer's disease…”
Get full text
Journal Article -
13
Hypertension accentuates reductions in CSF Aβ42 in elderly depressives: Biomarkers (non‐neuroimaging) / novel biomarkers
Published in Alzheimer's & dementia (01-12-2020)“…Abstract Background Hypertension (HTN) is a well‐established risk factor for Alzheimer’s disease (AD). Observations from animal and human PET studies indicate…”
Get full text
Journal Article -
14
Hypertension accentuates reductions in CSF Aβ42 in elderly depressives
Published in Alzheimer's & dementia (01-12-2020)“…Background Hypertension (HTN) is a well‐established risk factor for Alzheimer’s disease (AD). Observations from animal and human PET studies indicate that HTN…”
Get full text
Journal Article -
15
Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics
Published in Scientific reports (19-02-2019)“…In the Alzheimer’s disease (AD) continuum, the prodromal state of mild cognitive impairment (MCI) precedes AD dementia and identifying MCI individuals at risk…”
Get full text
Journal Article -
16
Higher CSF sTNFR1-related proteins associate with better prognosis in very early Alzheimer’s disease
Published in Nature communications (28-06-2021)“…Neuroinflammation is associated with Alzheimer’s disease, but the application of cerebrospinal fluid measures of inflammatory proteins may be limited by…”
Get full text
Journal Article -
17
Multimodal Hippocampal Subfield Grading For Alzheimer’s Disease Classification
Published in Scientific reports (25-09-2019)“…Numerous studies have proposed biomarkers based on magnetic resonance imaging (MRI) to detect and predict the risk of evolution toward Alzheimer’s disease…”
Get full text
Journal Article -
18
Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer’s Disease Neuroimaging Initiative cohort
Published in Scientific reports (02-04-2024)“…Alzheimer's disease (AD) is a neurodegenerative disease that commonly causes dementia. Identifying biomarkers for the early detection of AD is an emerging…”
Get full text
Journal Article -
19
Vitamin E in aging persons with Down syndrome: A randomized, placebo-controlled clinical trial
Published in Neurology (31-05-2016)“…OBJECTIVE:To determine whether vitamin E would slow the progression of cognitive deterioration and dementia in aging persons with Down syndrome (DS). METHODS:A…”
Get full text
Journal Article -
20
Author Correction: Predicting Alzheimer’s disease progression using multi-modal deep learning approach
Published in Scientific reports (01-08-2023)“…An amendment to this paper has been published and can be accessed via a link at the top of the paper…”
Get full text
Journal Article